ALPK3 heterozygous truncating variants cause late-onset hypertrophic cardiomyopathy with frequent apical involvement and apical aneurysm

Leora H Busse,Emily A Huth,M. Roselle Abraham,Theodore Abraham,Arun Padmanabhan,Julianne Wojciak,Gabrielle Wright,Rajani Aatre,Rachel Campagna,Erika Jackson,Sarah E Kreykes,Kimberly Lane,Lindsey Sawyer,Chelsea Stevens,Matthew J Thomas,Rebecca E VanDyke,Vasanth Vedantham,Emily Higgs

DOI: https://doi.org/10.1101/2024.11.14.24317359

2024-11-15

Abstract:Hypertrophic cardiomyopathy (HCM) is a genetically heterogeneous disorder with several established genotype-phenotype relationships. While biallelic truncating variants in the ALPK3 gene cause severe congenital HCM, recent studies have associated heterozygous truncating variants (ALPK3tv) with milder adult-onset HCM. Here we describe a multicenter cohort of 21 individuals with heterozygous ALPK3tv from 10 institutions in the United States, highlighting distinctive clinical characteristics compared to a control group of 132 patients with HCM caused by deleterious variants in sarcomeric genes. As compared to other HCM genotypes, ALPK3tv patients present at an older age (mean 57.25 years) with significantly lower left ventricular wall thickness (14.09 vs 19.78 mm with echocardiogram and 16.13 vs 21.13 mm with cardiac MRI), a lower prevalence of obstructive HCM (15% of ALPK3tv vs 45% of controls), and a strikingly higher incidence of apical aneurysm (22.22% vs. 2.40% in the control group). These results suggest a milder degree of hypertrophy in heterozygous ALPK3-related HCM as compared to other Mendelian causes of HCM, although the increased occurrence of apical aneurysms could have implications for ventricular arrhythmia risk. Our study underscores the importance of recognizing heterozygous ALPK3tv as a cause of adult-onset HCM and provides a comprehensive characterization of its clinical phenotype.

Cardiovascular Medicine

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the relationship between heterozygous ALPK3 truncating variants (ALPK3tv) and late - onset hypertrophic cardiomyopathy (HCM), especially its clinical features and pathological mechanisms. Specifically, the main research questions include: 1. **Association between ALPK3tv and HCM**: Confirm whether ALPK3tv can cause adult - onset HCM and describe the clinical manifestations of patients in this case. 2. **Comparison with traditional HCM**: Compare HCM patients related to ALPK3tv with HCM patients caused by other pathogenic genes (such as sarcomere genes) to determine the specific clinical features of ALPK3tv - related HCM. 3. **Incidence of apical aneurysm**: Explore the high incidence of apical aneurysm in ALPK3tv - related HCM and its impact on the prognosis of patients. ### Research background Hypertrophic cardiomyopathy (HCM) is a genetically heterogeneous disease, usually manifested as thickening of the left ventricular wall. Although it is known that biallelic ALPK3 truncating variants can cause severe congenital or childhood HCM, recent studies have shown that monoallelic ALPK3 truncating variants may also cause adult - onset HCM. However, the specific role of ALPK3tv in adult HCM and its clinical features are still controversial. ### Main findings Through a multicenter cohort study, the authors found: - **Late onset age**: The average onset age of HCM patients related to ALPK3tv was 57.25 years, which was significantly later than that of other types of HCM patients. - **Lower ventricular wall thickness**: The maximum left ventricular wall thickness (MWT) of ALPK3tv patients was significantly lower than that of other HCM patients. - **High incidence of apical aneurysm**: The incidence of apical aneurysm in ALPK3tv patients was 22.22%, much higher than 2.40% in the control group. - **Less obstructive HCM**: The incidence of obstructive HCM in ALPK3tv patients was only 15%, while that in the control group was 45%. - **Less arrhythmia**: The incidence of arrhythmia in ALPK3tv patients was relatively low, especially premature ventricular contractions (PVCs). ### Clinical significance These findings are helpful to better understand the role of ALPK3tv in HCM and provide more accurate diagnosis and treatment suggestions for clinicians. Especially for patients with apical aneurysms, closer monitoring and preventive measures may be required, such as anticoagulant therapy to reduce the risk of thromboembolism. ### Summary This study emphasizes the importance of identifying ALPK3tv as the cause of adult - onset HCM and provides a comprehensive description of its clinical phenotype, providing an important basis for future research and clinical management.

ALPK3 heterozygous truncating variants cause late-onset hypertrophic cardiomyopathy with frequent apical involvement and apical aneurysm

Spectrum and genotype-phenotype relationship of ALPK3 variants in Chinese patients with hypertrophic cardiomyopathy

The Involvement of ALPK3 in Hypertrophic Cardiomyopathy in East Asia

Characteristics of the beta myosin heavy chain gene Ala26Val mutation in a Chinese family with hypertrophic cardiomyopathy.

Inhibition of HSC70 Alleviates Hypertrophic Cardiomyopathy Pathology in Human Induced Pluripotent Stem Cell‐derived Cardiomyocytes with a MYBPC3 Mutation

The Novel Mitochondrial 16S Rrna 2336T>C Mutation is Associated with Hypertrophic Cardiomyopathy

[Advances in the Molecular Pathogenesis of Hypertrophic Cardiomyopathy].

Prevalence and phenotypes associated with ALPK3 null variants in a large French multicentric cohort: Confirming its involvement in hypertrophic cardiomyopathy

Abnormal Calcium Handling Properties Underlie Familial Hypertrophic Cardiomyopathy Pathology in Patient-Specific Induced Pluripotent Stem Cells.

Biallelic Truncating Mutations in ALPK3 Cause Severe Pediatric Cardiomyopathy

Association of Angiotensinogen Gene M235T Variant with Hypertrophic Cardiomyopathy

Novel Phenotype–genotype Correlations of Hypertrophic Cardiomyopathy Caused by Mutation in Α-Actin and Myosin-Binding Protein Genes in Three Unrelated Chinese Families

A pathogenic nonsense mutation (c.1522C>T) of the MYBPC3 gene is implicated with hypertrophic cardiomyopathy

Gender- and Age-Related Differences in Distinct Phenotypes of Hypertrophic Cardiomyopathy-Associated Mutation MYBPC3–E334K

Pathogenic Transthyretin Gene Mutations In Phenotypic Hypertrophic Cardiomyopathy: An Underrecognized Double Whammy

A Novel Truncating Variant in MYBPC3 Causes Hypertrophic Cardiomyopathy

Whole-exome sequencing identifies rare compound heterozygous mutations in the MYBPC3 gene associated with severe familial hypertrophic cardiomyopathy.

Association between hypertrophic cardiomyopathy and variations in sarcomere gene and calcium channel gene in adults

Natural history and clinical outcomes of patients with hypertrophic cardiomyopathy from thin filament mutations

Hypertrophic cardiomyopathy in MYBPC3 carriers in aging

A malignant phenotype of hypertrophic cardiomyopathy caused by Arg719Gln cardiac beta-myosin heavy-chain mutation in a Chinese family.